Back to VOYA INVESTMENT MANAGEMENT LLC VOYA INVESTMENT MANAGEMENT LLC

AIMTAIMT
9 quarters

Position history for VOYA INVESTMENT MANAGEMENT LLCVOYA INVESTMENT MANAGEMENT LLC's holdings in AIMMUNE THERAPEUTICS INC

As of its Q3 2020 13F, Voya Investment Management held 15,977 shares of AIMT (Aimmune Therapeutics), worth $550,000. Voya Investment Management's 13F filings listed AIMT from Q4 2018 to Q3 2020, 8 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$430,000

Total Shares Change

-17,985

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q3
Unchanged
15,977
0.0%
$550,0000.0%—
0
2020-Q2
Decreased
15,977
-29.9%
$267,0000.0%—
0
2020-Q1
Increased
22,805
+3.9%
$329,0000.0%—
24
2019-Q4
Increased
21,942
+17.2%
$734,0000.0%—
29
2019-Q3
Unchanged
18,717
0.0%
$392,0000.0%—
0
2019-Q2
Increased
18,717
+4.1%
$390,0000.0%—
25
2019-Q1
Unchanged
17,985
0.0%
$402,0000.0%—
0
2018-Q4
First report
17,985
-
$430,0000.0%—
0

Other major holders of AIMT: PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used